Quantitative approaches to drug development
Quantitative approaches to drug development
We provide consultancy services to help our clients reduce uncertainty in research and regulatory questions, increasing confidence in the development of new medicines that can improve patients’ lives. Learn more
About
Pharmetheus reduces uncertainty in all phases of drug development.
News
Read our story about Dr. Qing Xi, a testament to the international spirit at Pharmetheus. She is originally from Malaysia but has studied both in the UK and in New Zealand. She is now based at Pharmetheus’ head office in Uppsala – but makes frequent trips across the world.
Svetlana Freiberga, Data Programmer at Pharmetheus, gave three seminars at University of Latvia on Model-Informed-Drug-Development (MIDD) and pharmacometrics, also covering aspects of data programming. The response, according to Svetlana, was very positive: – I didn’t expect the interest to be as high as it was between professors of pharmacy. I held two separate in person presentations for pharmacy students and one…
Science & Services
How we work
Traceability, accountability, and independent quality control are of utmost importance to us, and embedded in our way of working.
Publications
Explore our scientific publications.
Explore our web
Model Informed Drug Development
A quantitative framework to support and inform development program strategies and decisions.
“Sharing with colleagues is why I love working here”
Sophie Peigné supports clients with expert and strategic advice in pharmacometrics as well as hands-on modeling analyses for compounds in all development phases.
History of Pharmetheus
Our journey is an exciting one. We began as a start-up that spinned off from Uppsala University. Today, we have grown into a global medium-sized company, adding value to drug development each day.